92 related articles for article (PubMed ID: 24957267)
1. Insights into substrate binding and catalysis in bacterial type I dehydroquinase.
Maneiro M; Peón A; Lence E; Otero JM; Van Raaij MJ; Thompson P; Hawkins AR; González-Bello C
Biochem J; 2014 Sep; 462(3):415-24. PubMed ID: 24957267
[TBL] [Abstract][Full Text] [Related]
2. Irreversible covalent modification of type I dehydroquinase with a stable Schiff base.
Tizón L; Maneiro M; Peón A; Otero JM; Lence E; Poza S; van Raaij MJ; Thompson P; Hawkins AR; González-Bello C
Org Biomol Chem; 2015 Jan; 13(3):706-16. PubMed ID: 25370445
[TBL] [Abstract][Full Text] [Related]
3. Comparison of different crystal forms of 3-dehydroquinase from Salmonella typhi and its implication for the enzyme activity.
Lee WH; Perles LA; Nagem RA; Shrive AK; Hawkins A; Sawyer L; Polikarpov I
Acta Crystallogr D Biol Crystallogr; 2002 May; 58(Pt 5):798-804. PubMed ID: 11976491
[TBL] [Abstract][Full Text] [Related]
4. Understanding the key factors that control the inhibition of type II dehydroquinase by (2R)-2-benzyl-3-dehydroquinic acids.
Peón A; Otero JM; Tizón L; Prazeres VF; Llamas-Saiz AL; Fox GC; van Raaij MJ; Lamb H; Hawkins AR; Gago F; Castedo L; González-Bello C
ChemMedChem; 2010 Oct; 5(10):1726-33. PubMed ID: 20815012
[TBL] [Abstract][Full Text] [Related]
5. Chemical Modification of a Dehydratase Enzyme Involved in Bacterial Virulence by an Ammonium Derivative: Evidence of its Active Site Covalent Adduct.
González-Bello C; Tizón L; Lence E; Otero JM; van Raaij MJ; Martinez-Guitian M; Beceiro A; Thompson P; Hawkins AR
J Am Chem Soc; 2015 Jul; 137(29):9333-43. PubMed ID: 26148116
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic basis of the inhibition of type II dehydroquinase by (2S)- and (2R)-2-benzyl-3-dehydroquinic acids.
Lence E; Tizón L; Otero JM; Peón A; Prazeres VF; Llamas-Saiz AL; Fox GC; van Raaij MJ; Lamb H; Hawkins AR; González-Bello C
ACS Chem Biol; 2013 Mar; 8(3):568-77. PubMed ID: 23198883
[TBL] [Abstract][Full Text] [Related]
7. The two types of 3-dehydroquinase have distinct structures but catalyze the same overall reaction.
Gourley DG; Shrive AK; Polikarpov I; Krell T; Coggins JR; Hawkins AR; Isaacs NW; Sawyer L
Nat Struct Biol; 1999 Jun; 6(6):521-5. PubMed ID: 10360352
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic insight into the reaction catalysed by bacterial type II dehydroquinases.
Coderch C; Lence E; Peón A; Lamb H; Hawkins AR; Gago F; González-Bello C
Biochem J; 2014 Mar; 458(3):547-57. PubMed ID: 24392963
[TBL] [Abstract][Full Text] [Related]
9. Exploring the water-binding pocket of the type II dehydroquinase enzyme in the structure-based design of inhibitors.
Blanco B; Sedes A; Peón A; Otero JM; van Raaij MJ; Thompson P; Hawkins AR; González-Bello C
J Med Chem; 2014 Apr; 57(8):3494-510. PubMed ID: 24689821
[TBL] [Abstract][Full Text] [Related]
10. Crystal structures of Staphylococcus aureus type I dehydroquinase from enzyme turnover experiments.
Nichols CE; Lockyer M; Hawkins AR; Stammers DK
Proteins; 2004 Aug; 56(3):625-8. PubMed ID: 15229896
[No Abstract] [Full Text] [Related]
11. Characterization of the type I dehydroquinase from Salmonella typhi.
Moore JD; Hawkins AR; Charles IG; Deka R; Coggins JR; Cooper A; Kelly SM; Price NC
Biochem J; 1993 Oct; 295 ( Pt 1)(Pt 1):277-85. PubMed ID: 8216229
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of new nanomolar competitive inhibitors of Helicobacter pylori type II dehydroquinase. Structural details of the role of the aromatic moieties with essential residues.
Prazeres VF; Tizón L; Otero JM; Guardado-Calvo P; Llamas-Saiz AL; van Raaij MJ; Castedo L; Lamb H; Hawkins AR; González-Bello C
J Med Chem; 2010 Jan; 53(1):191-200. PubMed ID: 19911771
[TBL] [Abstract][Full Text] [Related]
13. Reducing the Flexibility of Type II Dehydroquinase for Inhibition: A Fragment-Based Approach and Molecular Dynamics Study.
Peón A; Robles A; Blanco B; Convertino M; Thompson P; Hawkins AR; Caflisch A; González-Bello C
ChemMedChem; 2017 Sep; 12(18):1512-1524. PubMed ID: 28791799
[TBL] [Abstract][Full Text] [Related]
14. A prodrug approach for improving antituberculosis activity of potent Mycobacterium tuberculosis type II dehydroquinase inhibitors.
Tizón L; Otero JM; Prazeres VF; Llamas-Saiz AL; Fox GC; van Raaij MJ; Lamb H; Hawkins AR; Ainsa JA; Castedo L; González-Bello C
J Med Chem; 2011 Sep; 54(17):6063-84. PubMed ID: 21780742
[TBL] [Abstract][Full Text] [Related]
15. Discovery of Schaeffer's acid analogues as lead structures of mycobacterium tuberculosis type II dehydroquinase using a rational drug design approach.
Schmidt MF; Korb O; Howard NI; Dias MV; Blundell TL; Abell C
ChemMedChem; 2013 Jan; 8(1):54-8. PubMed ID: 23169689
[TBL] [Abstract][Full Text] [Related]
16. Self-Immolation of a Bacterial Dehydratase Enzyme by its Epoxide Product.
Lence E; Maneiro M; Sanz-Gaitero M; van Raaij MJ; Thompson P; Hawkins AR; González-Bello C
Chemistry; 2020 Jun; 26(36):8035-8044. PubMed ID: 32259333
[TBL] [Abstract][Full Text] [Related]
17. Crystallization of a type I 3-dehydroquinase from Salmonella typhi.
Boys CW; Bury SM; Sawyer L; Moore JD; Charles IG; Hawkins AR; Deka R; Kleanthous C; Coggins JR
J Mol Biol; 1992 Sep; 227(1):352-5. PubMed ID: 1522599
[TBL] [Abstract][Full Text] [Related]
18. Specific chemical modification of bacterial type I dehydroquinase--opportunities for drug discovery.
González-Bello C
Future Med Chem; 2015; 7(17):2371-83. PubMed ID: 26599605
[TBL] [Abstract][Full Text] [Related]
19. Flexible loop in the structure of S-adenosylmethionine synthetase crystallized in the tetragonal modification.
Fu Z; Hu Y; Markham GD; Takusagawa F
J Biomol Struct Dyn; 1996 Apr; 13(5):727-39. PubMed ID: 8723769
[TBL] [Abstract][Full Text] [Related]
20. Crystal structures of Helicobacter pylori type II dehydroquinase inhibitor complexes: new directions for inhibitor design.
Robinson DA; Stewart KA; Price NC; Chalk PA; Coggins JR; Lapthorn AJ
J Med Chem; 2006 Feb; 49(4):1282-90. PubMed ID: 16480265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
